Sort
1,049,261 grants matching “t cell”
Endothelial Redox State & Phenotype in Health & Disease
$2,403,760Kenneth Walsh · Boston University Medical Campus · P01 · FY2009 · HL
Bioengineered Antibodies in Cancer Imaging and Therapy
$2,403,727City Of Hope/Beckman Research Institute · P01 · FY2002 · CA
Neuronal differentiation in the retina
$2,403,660Anand Swaroop · National Eye Institute · ZIA · FY2010 · EY
Gene Therapy for Cystic Fibrosis
$2,403,656Ronald G Crystal · Weill Medical Coll Of Cornell Univ · P01 · FY2008 · HL
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,403,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2018 · HL
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
$2,403,292Brigham And Women'S Hospital · P50 · FY2005 · CA
Center on the Microenvironment and Metastasis
$2,403,199Michael L Shuler · Cornell University · U54 · FY2012 · CA
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm
$2,403,188Daniel B Rifkin · New York University School Of Medicine · P01 · FY2019 · HL
Life Course Cancer Epidemiology Cohort in Women
$2,403,177Walter C. Willett · Harvard School Of Public Health · U01 · FY2020 · CA
SPORE in Ovarian Cancer
$2,402,856Ie-Ming Shih · Johns Hopkins University · P50 · FY2025 · CA
Comprehensive Sickle Cell Center Program: Basic & Translational Research Program
$2,402,830Marie J. Stuart · Thomas Jefferson University · U54 · FY2008 · HL
Chemical Receptor Interactions In Reproduction And Hormonal Toxicity
$2,402,817Kenneth S Korach · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Center for Pediatric Research
$2,402,800David A Pearce · Sanford Research/Usd · P20 · FY2021 · GM
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
$2,402,774Richard G Wunderink · Northwestern University At Chicago · U19 · FY2024 · AI
PATHOLOGY SUPPORT FOR THE NIEHS
$2,402,721Lauren Staska · Integrated Laboratory Systems, Llc · N01 · FY2013 · ES
Novel therapeutics for vesicants and toxic inhaled chemicals (U54)
$2,402,664Carl W White · University Of Colorado Denver · U54 · FY2014 · ES
Functional consequences of stem and progenitor cell heterogeneity
$2,402,543David T Scadden · Massachusetts General Hospital · P01 · FY2021 · HL
Functional consequences of stem and progenitor cell heterogeneity
$2,402,543David T Scadden · Massachusetts General Hospital · P01 · FY2019 · HL
Functional consequences of stem and progenitor cell heterogeneity
$2,402,543David T Scadden · Massachusetts General Hospital · P01 · FY2020 · HL
SCORE Program at New Mexico State University, Las Cruces
$2,402,523New Mexico State University Las Cruces · S06 · FY2004 · GM
Proteopathies of the Aging Central Nervous System
$2,402,472Lennart Mucke · J. David Gladstone Institutes · P01 · FY2007 · AG
Metabolic Reprogramming and Pulmonary Vascular Disease in Congenital Heart Disease
$2,402,459Stephen M Black · Florida International University · P01 · FY2022 · HL
Rhinovirus Infections and Asthma in Children and Adolescents
$2,402,430Daniel J Jackson · University Of Wisconsin-Madison · P01 · FY2016 · HL
Aging and Immunity to Infections
$2,402,413Laura Haynes · Trudeau Institute, Inc. · P01 · FY2009 · AG
Signatures of Kinase Activation in Cancer
$2,402,208Todd R. Golub · Dana-Farber Cancer Inst · U54 · FY2007 · CA